Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)

NCT00739830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: ridaforolimus
DRUG: medroxyprogesterone acetate tablets OR megestrol acetate
DRUG: chemotherapy

Sponsor

Merck Sharp & Dohme LLC